We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits
BusinessFinance

Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits

Deanna Pogorelc
Deanna Pogorelc
Share
2 Min Read
SHARE

eye surgery drug kitsFirst published on MedCityNews.com. Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales forceeye surgery drug kitsFirst published on MedCityNews.com. Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales force and ramp up education efforts for Mitosol, its first product for eye surgeons.

What Mobius has done is take the drug mitomycin c, which ophthalmologists have been using for years off-label, and package it into a standard dosage kit that can be stored at room temperature for up to 24 months. The FDA has approved the kit for use in glaucoma surgery, and Mobius is pursuing additional applications in two other kinds of eye procedures.

St. Louis-based Cultivation Capital has just led a $3 million Series B for the company to support its expansion efforts.

“Having achieved critical regulatory, commercial, and market milestones, this investment will allow Mobius to accelerate the adoption of Mitosol, thereby improving convenience, occupational safety, consistency of patient treatment, and economics for patients, providers, and ophthalmologists,” Mobius President and CEO Ed Timm said in a statement.

More Read

health care management
3 Tips for Great Health Care Management
3 Big Healthcare Trends To Watch in 2015
HIMSS-15 in Chicago: The Wheels on the Bus Go Round and Round
From Yellow Pages to Google My Hospital
Health 2.0 Kicks Off in San Francisco

Glaucoma is one of the most common causes of blindness in the U.S. Medicines and surgeries are used to slow the progression of the disease by reducing pressure in the eyes.

Mitomycin c, which was initially introduced to the market as a chemotherapeutic agent, is used during surgery to prevent scarring that can block the drainage holes formed during surgery.

The St. Louis company last raised money in the fall of last year. Since then, it’s also received a payment indicator from CMS.

TAGGED:health start-ups!Mobius Therapeutics
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

Medtech Startups, November 2011

December 2, 2011

More Clinical Research Trials Moving to China

May 9, 2011
collaborative expertise in healthcare
BusinessPolicy & Law

Collaborative Expertise in Healthcare

October 22, 2014
Triple Aim and Telehealth
BusinesseHealthPolicy & LawPublic Health

How Telehealth Will Support the Triple Aim

August 26, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?